Nirav S. Jhaveri

CIK: 0002011481

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LGVN

Longeveron Inc.

Officer

IRD

Opus Genetics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

LGVN
Longeveron Inc.
Oct 1, 2026
Tax Payment(F)
Direct
742 shares at avg. $2.59$2K
LGVN
Longeveron Inc.
Aug 17, 2026
Award(A)
Direct
300K shares-
IRD
Opus Genetics, Inc.
Mar 13, 2025
Award(A)
Direct
52.5K shares-
IRD
Opus Genetics, Inc.
Feb 13, 2025
Tax Payment(F)
Direct
8.2K shares at avg. $1.15$9K

		Type	Shares	Price		Ownership
Oct 1, 2026	LGVN Longeveron Inc.	Tax Payment(F)	742	$2.59	$1,922	Direct
Aug 17, 2026	LGVN Longeveron Inc.	Award(A)	300,000	-	$0	Direct
Mar 13, 2025	IRD Opus Genetics, Inc.	Award(A)	52,500	-	-	Direct
Feb 13, 2025	IRD Opus Genetics, Inc.	Tax Payment(F)	8,207	$1.15	$9,438	Direct

1-4 of 4 transactions

About Jhaveri Nirav S.

Jhaveri Nirav S. (SEC CIK 0002011481) files insider reports with the SEC as Chief Financial Officer of Longeveron Inc. (LGVN) and Chief Financial Officer of Opus Genetics, Inc. (IRD).

Signal8 holds 5 ownership filings by Jhaveri Nirav S. (1 Form 3, 4 Form 4), filed between Feb 18, 2025 and Oct 5, 2026. Those filings report 4 transactions, from Feb 13, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jhaveri Nirav S.'s filings is in MIAMI, FL.

Recent filings by Jhaveri Nirav S.

Oct 1, 2026: Tax withholding of LGVN shares (Form 4, code F).
Aug 17, 2026: Grant or award of LGVN shares (Form 4, code A).
Mar 13, 2025: Grant or award of IRD shares (Form 4, code A).
Feb 13, 2025: Tax withholding of IRD shares (Form 4, code F).

Other insiders filing for Longeveron Inc. (LGVN)

Willard Stephen H, Chief Executive Officer
Agafonova Nataliya, Chief Medical Officer
Lehr Paul T, General Counsel, Secretary
Blass Devin, CTO & SVP of CMC
Hajjar Roger Joseph, Director
Soffer Rock, Director

How to read Form 4 transaction codes